Bionor Immuno / news
28 Jan 2009 ... According to the agreement, Bachem supplies the active ingredients for Bionor Immuno's lead product, Vacc-4x, an HIV-vaccine based on a ...
http://www.bionorimmuno.com/news2009_Bachem.html...
|
Bionor Immuno Release: Researchers Find That Vacc-4x Therapeutic ...
21 Oct 2009 ... Bionor Immuno is in the process of initiating a new Vacc-4x program that seeks to help people with HIV who do not respond adequately to ...
http://www.biospace.com/news_story.aspx?NewsEntityId=159998...
|
Bionor Immuno
HIV · OTHER INDICATIONS. DEVELOPMENT PIPELINE. THERAPEUTIC FOCUS. Bionor Immuno AS is a multidisciplinary biomedical drug development company with a ...
http://www.bionorimmuno.com/...
|
Bionor Immuno Advances HIV Peptide-Based Therapeutic Immunization ...
5 Aug 2008 ... MEXICO CITY--(BUSINESS WIRE)--Bionor Immuno today announced that it has advanced its efforts to develop the first HIV therapeutic ...
http://www.biospace.com/news_story.aspx?NewsEntityId=105768...
|
Bionor Immuno / news
Bionor Immuno's new therapeutic HIV vaccine. - My experience of this new HIV ... Bionor Immuno has developed a therapeutic HIV vaccine that looks like it ...
http://www.bionorimmuno.com/stories.html...
|
Bionor Immuno Welcomes Renowned Virologist Robert Redfield, MD...
Among the diseases targeted are chronic infections caused by HIV, Hepatitis C ( HCV), Human Papilloma Virus (HPV) and Influenza. Bionor Immuno's platform ...
http://www.biospace.com/news_story.aspx?NewsEntityId=159592...
|
Bionor Immuno / news
Mexico City, Mexico – August 4, (PR Newswire) —Bionor Immuno today announced that it has advanced its efforts to develop the first HIV therapeutic ...
http://www.bionorimmuno.com/news2008_phaseIIB.html...
|
Novel peptide-based HIV-1 immunotherapy.
Novel peptide-based HIV-1 immunotherapy. Sommerfelt MA, Nyhus J, Sørensen B. Bionor Immuno AS, Strømdaljordet 4, PO Box 1823 Gulset, NO-3703 Skien, Norway.
...
http://www.ncbi.nlm.nih.gov/pubmed/15006729...
|
Bionor Immuno / news
Researchers Hope Bionor Immuno's Immune Modulating Investigational Treatment Gives HIV Patients a Safe Break from Anti Retroviral Therapy-- ...
http://www.bionorimmuno.com/news2008_award.html...
|
Prospects for HIV-1 therapeutic immunisation and vaccination: the ...
Director of Research Bionor Immuno AS, Klostergata 33, NO-3732 Skien, Norway. ms @bionorimmuno.com. BACKGROUND: Human immunodeficiency virus (HIV)-1 ...
http://www.ncbi.nlm.nih.gov/pubmed/18476786...
|
